View all newsletters
Receive our newsletter – data, insights and analysis delivered to you
  1. Deals Analysis
April 27, 2021

Medical Devices industry M&A deals total $3.86bn globally in March 2021

Total medical devices industry M&A deals worth $3.86bn were announced globally in March 2021, led by Boston Scientific’s $1.07bn asset transaction with Lumenis, according to GlobalData’s deals database.

  • Embed this chart

    Embed this chart into your website

    Copy and paste the image source into your website to display the chart.

The value marked an increase of 39.4% over the previous month of $2.77bn and a drop of 49.3% when compared with the last 12-month average, which stood at $7.61bn.

Comparing M&A deals value in different regions of the globe, North America held the top position, with total announced deals in the period worth $2.41bn. At the country level, the US topped the list in terms of deal value at $2.23bn.

In terms of volumes, North America emerged as the top region for medical devices industry M&A deals globally, followed by Europe and then Asia-Pacific.

The top country in terms of M&A deals activity in March 2021 was the US with 23 deals, followed by the Germany with four and Canada with three.

In 2021, as of March, medical devices M&A deals worth $30.7bn were announced globally, marking an increase of 1029.1% year on year.

medical devices industry M&A deals in March 2021: Top deals

The top five M&A deals accounted for 72.5% of the overall value during March 2021.

The combined value of the top five medical devices M&A deals stood at $2.8bn, against the overall value of $3.86bn recorded for the month.

The top five medical devices industry M&A deals of March 2021 tracked by GlobalData were:

1) Boston Scientific’s $1.07bn asset transaction with Lumenis

2) The $695m acquisition of Resolution Bioscience by Agilent Technologies

3) Agiliti’s $475m acquisition of Northfield Medical

4) The $320m acquisition of Asuragen by Bio Techne

5) Organon &’s acquisition of Alydia Health for $240m.

Related Companies

Verdict deals analysis methodology

This analysis considers only announced and completed deals from the GlobalData financial deals database and excludes all terminated and rumoured deals. Country and industry are defined according to the headquarters and dominant industry of the target firm. The term ‘acquisition’ refers to both completed deals and those in the bidding stage.

GlobalData tracks real-time data concerning all merger and acquisition, private equity/venture capital and asset transaction activity around the world from thousands of company websites and other reliable sources.

More in-depth reports and analysis on all reported deals are available for subscribers to GlobalData’s deals database.

NEWSLETTER Sign up Tick the boxes of the newsletters you would like to receive. The top stories of the day delivered to you every weekday. A weekly roundup of the latest news and analysis, sent every Friday. The medical device industry's most comprehensive news and information delivered every month.
I consent to GlobalData UK Limited collecting my details provided via this form in accordance with the Privacy Policy
SUBSCRIBED

THANK YOU